The Clayton memorial lecture, 1978: "Is immunoprophylaxis in leprosy feasible?"

Monoclonal antibodies against mycobacterial antigens.

Immunology today·2014

Malaria vaccine development: current status.

Parasitology today (Personal ed.)·2006

[WHO's malaria program Roll Back Malaria].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2000

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.

Lancet (London, England)·1999

A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran.

Vaccine·1999

Research and training in tropical diseases.

World health forum·1999

The Leprosy Post-Exposure Prophylaxis (LPEP) programme: update and interim analysis.

Leprosy review·2023

Protocol for a Randomised Controlled Trial Investigating Decompression for Leprous Neuropathy (The DELN Protocol).

Leprosy review·2018

Adaptive shortening of long flexor in patients with claw hand: A short report.

Leprosy review·2018

Difficult diagnosis and challenging treatment – a report on leprosy.

Leprosy review·2018

Strongyloides hyper infection in a steroid dependent leprosy patient.

Leprosy review·2018

Autochthonous lepromatous leprosy in a Spanish woman with burns on both feet and skin lesions.

Leprosy review·2018

[Regulatory T Cells and Cancer-Focus on Renal Cell Carcinoma].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

Identification of broadly tumour-reactive γδ TCRs from multiple myeloma.

Nature·2026

Immunogenic cell death and tertiary lymphoid structures: bridging tumour cell death and immune organization.

Nature reviews. Immunology·2026

Sentinel lymph node biopsy in melanoma: Redundant in the neoadjuvant era.

European journal of cancer (Oxford, England : 1990)·2026

Accountability and the seemingly imponderables in NHS patient safety.

British journal of nursing (Mark Allen Publishing)·2026

MG53 suppresses IRF7 to reprogram macrophages and promote antitumor immunity in pancreatic ductal adenocarcinoma.

Cell reports·2026

Related Experiment Videos

The Clayton memorial lecture, 1978: "Is immunoprophylaxis in leprosy feasible?"

Related Concept Videos

Monoclonal antibodies against mycobacterial antigens.

Malaria vaccine development: current status.

[WHO's malaria program Roll Back Malaria].

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.

A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran.

Research and training in tropical diseases.

The Leprosy Post-Exposure Prophylaxis (LPEP) programme: update and interim analysis.

Protocol for a Randomised Controlled Trial Investigating Decompression for Leprous Neuropathy (The DELN Protocol).

Adaptive shortening of long flexor in patients with claw hand: A short report.

Difficult diagnosis and challenging treatment – a report on leprosy.

Strongyloides hyper infection in a steroid dependent leprosy patient.

Autochthonous lepromatous leprosy in a Spanish woman with burns on both feet and skin lesions.

[Regulatory T Cells and Cancer-Focus on Renal Cell Carcinoma].

Identification of broadly tumour-reactive γδ TCRs from multiple myeloma.

Immunogenic cell death and tertiary lymphoid structures: bridging tumour cell death and immune organization.

Sentinel lymph node biopsy in melanoma: Redundant in the neoadjuvant era.

Accountability and the seemingly imponderables in NHS patient safety.

MG53 suppresses IRF7 to reprogram macrophages and promote antitumor immunity in pancreatic ductal adenocarcinoma.

Related Experiment Videos

The Clayton memorial lecture, 1978: "Is immunoprophylaxis in leprosy feasible?"

Related Concept Videos

Related Articles